Company Study of Guangxi Wuzhou Zhongheng Group
  • Aug/2007
  • Hard Copy
  • USD $349
  • Pages:23
  • Single User License
    (PDF Unprintable)       
  • USD $349
  • Code:
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $698
  • Hard Copy + Single User License
  • USD $399

In 2006, the company received the main business revenue of RMB 321.1685 million, of which the pharmaceutical industry accounted for 62.83%; the profit of main business reached RMB 154.1201 million and, the net profit amounted to RMB 19.6635 million.

Xueshuantong Freeze-Dry Powder for Injection, the company's core pharmaceutical product, is an important variety in cardiovascular and cerebrovascular fields. At present, the company's full-loaded monthly production capacity can not meet the increased market demand, so some products are contracted to Chongqing Yaoyou Pharmaceutical temporarily. It is estimated that the sales volume of Xueshuantong Freeze-Dry Powder for Injection will be 25 million doses in 2007, and 40 million in 2008, 50 million in 2009.

Main Business Structure of Zhongheng Group, 2006


Market Pattern of Drugs Used in Hospitals, 2006


1 Company profile
1.1 Equity rights transferred by SASAC
1.2 Strategies of the company
1.3 Management and marketing of the company

2. Analysis on cardiovascular drugs
2.1 Analysis on the market
2.2 Traditional Chinese medicine in cardiovascular field
2.3 Market status of the company's Xueshuantong (Freeze-Dry) Powder for Injection

3. Development of the company
3.1 Patent
3.2 Development of the company's pharmaceutical business in 2007
3.3 Status quo of the company's new base
Equity structure of the company
Main business structure of Zhongheng Group, 2006
Market pattern of drugs used in hospitals, 2006
Variation in medicine sales income of Zhongheng Group
Parts of financial indicators of Zhongheng Group
Share and growth rate of sub-classified cardiovascular drugs, 2006
Classification of cardiovascular drugs and main varieties
Comparison of main traditional Chinese injection varieties
Patent application for main inventions of Guangxi Wuzhou Pharmaceuticals (Group) Co., Ltd

China Pharmaceutical Distribution Industry Report, 2019-2026

The Chinese pharmaceutical distribution market has been expanding steadily over the recent years, being valued at RMB2,330.3 billion in 2019 with a year-on-year increase of 8.9%, of which the pharmace...

China Pharmaceutical Distribution Industry Report, 2019-2025

China’s pharmaceutical distribution industry has sustained steady growth over the years. In 2018, the market was worth RMB2,194.5 billion, a 9.6% rise from RMB2,001.6 billion (up by 8.4% YoY) in 2017,...

China Pharmaceutical Packaging Industry Report, 2019-2025

Being incentivized by the burgeoning pharmaceuticals industry, Chinese pharmaceutical packaging market size sustained growth rates of around 10% in recent years, and outstripped RMB100 billion in 2018...

China Blood Product Industry Report, 2018-2022

The blood product industry in China develops under stimulation of industry policies and downstream demand. The country recorded total lot release volume of 64.11 million bottles of blood products in 2...

China Pharmaceutical Distribution Industry Report, 2017-2021

The Chinese pharmaceutical distribution market has developed steadily but at a slower rate in recent years. The industry rose by 10.4% year on year to RMB1.8393 trillion in 2016 and is expected to hit...

China Blood Product Industry Report, 2017-2021

China’s blood product market size mushroomed in 2016 under the impetus of liberalization of limited-price policy, price rises in varying degrees and lot release volume growth for blood products in 201...

China Pharmaceutical Packaging Industry Report, 2016-2021

Under the impetus of the fast-growing downstream pharmaceutical industry, Chinese pharmaceutical packaging market size increased year by year at the CAGR of 11.2% during 2010-2016. From 2017 to 2021, ...

China Pharmaceutical Glass Packaging Industry Report, 2014-2017

In recent years, advances in new healthcare reform have boosted market demand from China pharmaceuticals industryand driven growth in the demand from pharmaceutical packaging industry. In 2014, the Ch...

China Vitamin Industry Report,2014-2017

China is the world's largest production base of vitamins, with vitamin C and vitamin E as its most important products, wherein vitamin C and related products account for more than 60% of its total out...

China Chemical Pharmaceutical Industry Report, 2013-2016

Chemical pharmaceutical consists mainly of chemical drug preparation and active pharmaceutical ingredient (API), and the gross margin of chemical drug preparation industry is generally higher than tha...

China Pharmaceutical Distribution Industry Report, 2013

Thanks to the continuous advancement in new medical reform, China’s pharmaceutical distribution industry has maintained a fairly rapid growth in recent years, with the sales value showed a CAGR of rou...

China Pharmaceutical Glass Packaging Industry Report, 2013-2016

Influenced by the substitution of plastic, aluminum foil and other new packaging materials as well as the declining packaging material purchase prices incurred by the medical reform, China pharmaceuti...

China Chinese Patent Medicine Industry Report, 2013-2016

Chinese patent medicine refers to the certain dosage forms of medicine, under the guidance of TCM (traditional Chinese medicine) theory, made from traditional Chinese medicinal materials in accordance...

Global and China Insulin Industry Report, 2013-2017

As the third largest human health disease following neoplastic disease, cardiovascular and cerebrovascular diseases, the number of diabetic patients has continued growing from 246 million in 2007 to 3...

China Large Volume Parenteral (LVP) Industry Report, 2013-2015

Under the context of China's medical reform and sustainable development of the pharmaceutical market, the output and demand of Large Volume Parenteral (LVP) which is one of the top five Chinese prepar...

China Vitamin Industry Report, 2012-2015

As a great power of vitamin production and export, China has long been known as the world’s vitamin production base. In recent years, its vitamin exports on external demand accounted for about 80% of ...

China Pharmaceutical Equipment Industry Report, 2012-2015

Driven by the new GMP certification as well as the brisk downstream demand, China pharmaceutical equipment industry has seen steady progress in sales volume and technological content of products over ...

China Genetic Engineering Drug Industry Report, 2011-2012

China gets a late start in developing genetic engineering drug industry, but has achieved leapfrog advance. At present, China has at least one hundred enterprises involved in genetic engineering drugs...

2005- All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号